Abiopharma

🔍 TALWALKAR ABHIJIT Y (Director)

Company: iRhythm Holdings, Inc. (IRTC)

Report Date: 2026-05-11

Detailed Transactions and Holdings:

• Acquired 5,312 shares of Common Stock at $10.71 per share (Direct)
  Date: 2026-05-11 | Code: P | equity_swap_involved: 0 | shares_owned_after: 25,611.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 940 shares of Common Stock at $116.0542 per share (Direct)
  Date: 2026-05-11 | Code: S | equity_swap_involved: 0 | shares_owned_after: 24,671.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 642 shares of Common Stock at $116.9812 per share (Direct)
  Date: 2026-05-11 | Code: S | equity_swap_involved: 0 | shares_owned_after: 24,029.00 | transaction_form_type: 4 | Footnotes: F1, F3
• Sold 2,293 shares of Common Stock at $118.0163 per share (Direct)
  Date: 2026-05-11 | Code: S | equity_swap_involved: 0 | shares_owned_after: 21,736.00 | transaction_form_type: 4 | Footnotes: F1, F4
• Sold 1,147 shares of Common Stock at $119.1557 per share (Direct)
  Date: 2026-05-11 | Code: S | equity_swap_involved: 0 | shares_owned_after: 20,589.00 | transaction_form_type: 4 | Footnotes: F1, F5
• Sold 290 shares of Common Stock at $120.53 per share (Direct)
  Date: 2026-05-11 | Code: S | equity_swap_involved: 0 | shares_owned_after: 20,299.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 5,312 shares of Employee Stock Option (right to buy) at $10.71 per share (Derivative)
  Date: 2026-05-11 | Code: M | Expires: 2026-05-23 | Exercise: 2016-06-23 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F6

Footnotes:

• F1: All transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan established by Mr. Talwalkar on May 12, 2025.
• F2: Represents the weighted-average sale price per share of a series of transactions, all of which were executed on May 11, 2026. The actual sale prices ranged from a low of $115.61 to a high of $116.61, inclusive. Mr. Talwalkar undertakes to provide upon request of the SEC staff, iRhythm Holdings, Inc. or any security holder of iRhythm Holdings, Inc., full information regarding the numbers of shares sold at each price within the range. The weighted-average sale price reflected has been rounded to 4 decimal points.
• F3: Represents the weighted-average sale price per share of a series of transactions, all of which were executed on May 11, 2026. The actual sale prices ranged from a low of $116.62 to a high of $117.31, inclusive. Mr. Talwalkar undertakes to provide upon request of the SEC staff, iRhythm Holdings, Inc. or any security holder of iRhythm Holdings, Inc., full information regarding the numbers of shares sold at each price within the range. The weighted-average sale price reflected has been rounded to 4 decimal points.
• F4: Represents the weighted-average sale price per share of a series of transactions, all of which were executed on May 11, 2026. The actual sale prices ranged from a low of $117.68 to a high of $118.45, inclusive. Mr. Talwalkar undertakes to provide upon request of the SEC staff, iRhythm Holdings, Inc. or any security holder of iRhythm Holdings, Inc., full information regarding the numbers of shares sold at each price within the range. The weighted-average sale price reflected has been rounded to 4 decimal points.
• F5: Represents the weighted-average sale price per share of a series of transactions, all of which were executed on May 11, 2026. The actual sale prices ranged from a low of $118.70 to a high of $119.63, inclusive. Mr. Talwalkar undertakes to provide upon request of the SEC staff, iRhythm Holdings, Inc. or any security holder of iRhythm Holdings, Inc., full information regarding the numbers of shares sold at each price within the range. The weighted-average sale price reflected has been rounded to 4 decimal points.
• F6: The option, originally granted on May 23, 2016 for 21,248 shares, vested in thirty-six equal monthly installments. This option has an expiration date of May 23, 2026. The Rule 10b5-1 trading plan of Mr. Talwalkar solely covers shares subject to options expiring in 2026 and 2027.